Viewing StudyNCT00456248



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00456248
Status: TERMINATED
Last Update Posted: 2012-10-15
First Post: 2007-04-02

Brief Title: Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin
Sponsor: Kadmon Corporation LLC
Organization: Kadmon Corporation LLC

Organization Data

Organization: Kadmon Corporation LLC
Class: INDUSTRY
Study ID: VRX-CIFN-402
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Kadmon Corporation LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators